Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Entasis Therapeutics Holdings Inc (NQ: ETTX ) N/A UNCHANGED Last Price Updated: 3:59 PM EDT, Jul 8, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Entasis Therapeutics Holdings Inc Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022 October 12, 2022 Six abstracts selected for presentation, including three oral presentations From Entasis Therapeutics Holdings Inc. Via GlobeNewswire Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc. July 08, 2022 From Innoviva, Inc. Via Business Wire Scott+Scott Attorneys at Law LLP Investigates Innoviva Buyout of Entasis – ETTX June 03, 2022 From Scott+Scott Attorneys at Law LLP Via Business Wire ENTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Entasis Therapeutics Holdings Inc. - ETTX May 23, 2022 From Kahn Swick & Foti, LLC Via Business Wire ETTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Entasis Therapeutics Holdings Inc. Is Fair to Shareholders May 23, 2022 From Halper Sadeh LLP Via Business Wire Innoviva to Acquire Entasis Therapeutics May 23, 2022 From Innoviva, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
